Company / Shareholders' Equity
NeuroPace Inc Shareholders' Equity History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$8.0M
FY2025
5-year range
-$147.8M / $73.5M
FY2021-FY2025
Trend
-61.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity has declined for 3 consecutive years, from $74M in FY2022 to $8M in FY2025.
Based on SEC 10-K filings.
$8M in FY2025 with a 3-year CAGR of -52.2%.
Declined from $35M to $8M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -52.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- NeuroPace Inc's shareholders' equity has declined for 3 consecutive years.
- 3-year CAGR of -52.2%, indicating a declining trend.
- In FY2025, shareholders' equity decreased 61.2% year-over-year.
- Peak shareholders' equity was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.0M | -61.2% |
| FY2024 | $20.7M | -40.6% |
| FY2023 | $34.8M | -52.7% |
| FY2022 | $73.5M | +149.7% |
| FY2021 | -$147.8M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026